title: Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram.
abstract: BACKGROUND
  Generalized anxiety disorder (GAD) is a common disorder in older adults, which has been linked to hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this age group. The authors examined whether treatment of GAD in older adults with a selective serotonin reuptake inhibitor (SSRI) corrects this HPA axis hyperactivity.
  
  
  METHODS
  The authors examined adults aged 60 years and older with GAD in a 12-week randomized controlled trial comparing the SSRI escitalopram with placebo. The authors collected salivary cortisol at six daily time points for 2 consecutive days to assess peak and total (area under the curve) cortisol, both at baseline and posttreatment.
  
  
  RESULTS
  Compared with placebo-treated patients, SSRI-treated patients had a significantly greater reduction in both peak and total cortisol. This reduction in cortisol was limited to patients with elevated (above the median) baseline cortisol, in whom SSRI-treated patients showed substantially greater reduction in cortisol than did placebo-treated patients. Reductions in cortisol were associated with improvements in anxiety. Additionally, genetic variability at the serotonin transporter promoter predicted cortisol changes.
  
  
  CONCLUSIONS
  SSRI treatment of GAD in older adults reduces HPA axis hyperactivity. Further research should determine whether these treatment-attributable changes are sustained and beneficial.
authors.affiliation: Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA. lenzee@wustl.edu
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Lenze
authors.forename: Rose C
authors.initials: RC
authors.lastname: Mantella
authors.forename: Peichang
authors.initials: P
authors.lastname: Shi
authors.forename: Alison M
authors.initials: AM
authors.lastname: Goate
authors.forename: Petra
authors.initials: P
authors.lastname: Nowotny
authors.forename: Meryl A
authors.initials: MA
authors.lastname: Butters
authors.forename: Carmen
authors.initials: C
authors.lastname: Andreescu
authors.forename: Paul A
authors.initials: PA
authors.lastname: Thompson
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Rollman
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D015283:Citalopram / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis* / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000503:physiopathology; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D012463:Saliva / Q000737:chemistry; D050486:Serotonin Plasma Membrane Transport Proteins / Q000187:drug effects / Q000235:genetics; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D015283:Citalopram; D006854:Hydrocortisone; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; C493230:SLC6A4 protein, human
references.citation: Psychoneuroendocrinology. 2008 May;33(4):517-29
references.pmid: 18337016
references.citation: Am J Geriatr Psychiatry. 2010 Jan;18(1):42-50
references.pmid: 20094017
references.citation: Life Sci. 1997;61(22):2239-46
references.pmid: 9393943
references.citation: Expert Rev Neurother. 2008 Jan;8(1):111-20
references.pmid: 18088204
references.citation: Neuroimage. 2005 Jul 1;26(3):891-9
references.pmid: 15955499
references.citation: Rev Neurosci. 1999;10(2):117-39
references.pmid: 10658955
references.citation: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14158-63
references.pmid: 16983099
references.citation: Biol Psychiatry. 2008 Oct 15;64(8):701-7
references.pmid: 18571624
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5
references.pmid: 15574496
references.citation: JAMA. 2009 Jan 21;301(3):295-303
references.pmid: 19155456
references.citation: Psychoneuroendocrinology. 2008 Jul;33(6):773-81
references.pmid: 18407426
references.citation: Neuron. 2007 Dec 6;56(5):924-35
references.pmid: 18054866
references.citation: J Consult Clin Psychol. 2003 Apr;71(2):309-19
references.pmid: 12699025
references.citation: Psychiatry Res. 2009 Aug 30;173(2):121-7
references.pmid: 19559575
references.citation: Mol Psychiatry. 2007 Jun;12(6):544-55
references.pmid: 17353910
references.citation: Arch Gen Psychiatry. 2007 Jul;64(7):810-8
references.pmid: 17606815
references.citation: Am J Geriatr Psychiatry. 2006 Aug;14(8):684-93
references.pmid: 16861373
references.citation: Am J Psychiatry. 2000 Jan;157(1):89-95
references.pmid: 10618018
references.citation: Psychoneuroendocrinology. 2008 Feb;33(2):246-54
references.pmid: 18082975
references.citation: Biol Psychiatry. 2004 Jul 15;56(2):113-20
references.pmid: 15231443
references.citation: J Clin Endocrinol Metab. 1996 Jul;81(7):2468-73
references.pmid: 8675562
references.citation: Psychoneuroendocrinology. 2001 Apr;26(3):225-40
references.pmid: 11166486
references.citation: Behav Res Ther. 1990;28(6):487-95
references.pmid: 2076086
references.citation: J Neurosci. 1994 May;14(5 Pt 1):2893-903
references.pmid: 8182446
references.citation: Psychoneuroendocrinology. 2003 Oct;28(7):916-31
references.pmid: 12892658
references.citation: Am J Geriatr Psychiatry. 2006 Apr;14(4):325-33
references.pmid: 16582041
references.citation: Am J Geriatr Psychiatry. 2006 Apr;14(4):334-42
references.pmid: 16582042
references.citation: Am J Psychiatry. 2006 Dec;163(12):2164-9
references.pmid: 17151169
references.citation: Nat Neurosci. 2005 Jun;8(6):828-34
references.pmid: 15880108
references.citation: Psychoneuroendocrinology. 2005 Jan;30(1):80-91
references.pmid: 15358445
references.citation: Am J Geriatr Psychiatry. 2007 Jun;15(6):522-9
references.pmid: 17545451
references.citation: Dialogues Clin Neurosci. 2006;8(4):433-44
references.pmid: 17290801
references.citation: Nat Neurosci. 2005 Jan;8(1):20-1
references.pmid: 15592465
references.citation: J Affect Disord. 2008 Mar;106(3):307-13
references.pmid: 17727959
references.citation: J Neurosci. 2006 Apr 19;26(16):4415-25
references.pmid: 16624961
references.citation: Mol Psychiatry. 2009 Jan;14(1):95-105
references.pmid: 17912249
references.citation: Biol Psychiatry. 2007 Sep 1;62(5):479-86
references.pmid: 17481591
references.citation: Biol Psychiatry. 2008 May 1;63(9):847-51
references.pmid: 18005940
references.citation: Am J Psychiatry. 2006 Sep;163(9):1588-93
references.pmid: 16946185
references.citation: J Affect Disord. 2008 Aug;109(3):233-50
references.pmid: 18155775
references.citation: J Psychiatr Res. 2004 May-Jun;38(3):305-12
references.pmid: 15003436
references.citation: Am J Geriatr Psychiatry. 2006 Apr;14(4):295-8
references.pmid: 16582037
references.citation: Psychosom Med. 2007 Nov;69(8):762-8
references.pmid: 17942837
references.citation: Br J Med Psychol. 1959;32(1):50-5
references.pmid: 13638508
references.citation: Am J Psychiatry. 2004 Nov;161(11):2081-90
references.pmid: 15514410
references.citation: Neuroendocrinology. 1995 Apr;61(4):464-70
references.pmid: 7783860
references.citation: J Psychiatr Res. 2009 May;43(8):777-83
references.pmid: 19054531
references.citation: N Engl J Med. 1998 Jan 15;338(3):171-9
references.pmid: 9428819